학술논문
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Document Type
Article
Author
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, November 2008, 57(11):1599-1609)
Subject
Language
English
ISSN
03407004